[1]黄 婷,李绍旦,高 路,等.中医药防治心肌缺血再灌注损伤的研究进展[J].医学信息,2018,31(04):31-33,37.[doi:10.3969/j.issn.1006-1959.2018.04.011]
　HUANG Ting,LI Shao-dan,GAO Lu,et al.Research Progress on the Prevention and Treatment of Myocardial Ischemia and Reperfusion Injury by Traditional Chinese Medicine[J].Journal of Medical Information,2018,31(04):31-33,37.[doi:10.3969/j.issn.1006-1959.2018.04.011]
点击复制

中医药防治心肌缺血再灌注损伤的研究进展()
分享到：

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
31卷
期数:
2018年04期
页码:
31-33,37
栏目:
综述
出版日期:
2018-02-15

文章信息/Info

Title:
Research Progress on the Prevention and Treatment of Myocardial Ischemia and Reperfusion Injury by Traditional Chinese Medicine
文章编号:
1006-1959（2018）04-0031-04
作者:
黄 婷1; 2; 李绍旦2; 高 路2; 王 鹏1; 刘 毅2; 杨明会2
1.北京中医药大学，北京 100029；2.中国人民解放军总医院，北京 100853
Author(s):
HUANG Ting1; 2; LI Shao-dan2; GAO Lu2; WANG Peng1; LIU Yi2; YANG Ming-hui2
1.Beijing University of Traditional Chinese Medicine,Beijing 100029,China;2.Chinese People's Liberation Army General Hospital,Beijing 100853,China
关键词:
心肌缺血再灌注损伤; 中医药; 研究进展; 病理机制
Keywords:
Key words：Myocardial ischemia-reperfusion injury; Traditional Chinese medicine; Research progress; Pathological mechanism
分类号:
R259
DOI:
10.3969/j.issn.1006-1959.2018.04.011
文献标志码:
A
摘要:
中医药是中华民族的宝贵财富，其治疗理念正逐渐被世界所接受，中医以疏通经脉、渗灌气血、濡养心神指导临床，其文献中无心肌缺血再灌注损伤一词，依据其病理过程中表现出的症状，多归属于中医的“胸痹”“心悸”和“真心痛”等范畴，现将MIRI的病理机制及中医药治疗进行整理，了解中医药对MIRI的干预治疗，从而为临床诊疗提供应用价值。
Abstract:
Abstract：Traditional Chinese medicine is a valuable asset to the Chinese nation.Its concept of treatment is gradually being accepted by the world.Traditional Chinese medicine(TCM)is designed to unblock meridians and infiltrate qi and blood.It guides the clinical practice.There is no evidence of myocardial ischemia-reperfusion injury in its literature.According to its pathological process showed symptoms,mostly attributed to traditional Chinese medicine"chest paralysis,""heart palpitations"and"true heartache"and other fields, now MIRI pathological mechanism and treatment of traditional Chinese medicine to organize and understand the traditional Chinese medicine MIRI intervention treatment,so as to provide clinical value for clinical treatment.

参考文献/References:

[1]栾彤.丹参酮注射液对心肌缺血再灌注损伤的保护作用及其不同中医证型疗效差异[D].南京中医药大学,2012.
[2]沈继龙,朱克军,李增男,等.丹参多酚酸盐预处理对大鼠心肌缺血再灌注损伤的防护作用[J].临床心血管病杂志,2012,28(09):707-710.
[3]吴扬,潘瑞蓉,王玉琴.藏红花素对大鼠缺氧心肌的保护作用及其机制研究[J].中国循环杂志,2011,26(01):61-64.
[4]孙经武,王艳艳,房灿.藏红花酸预处理对大鼠心肌缺血再灌注损伤中炎症反应和细胞凋亡的影响及其机制[J].中国循环杂志,2015,30(02):172-175.
[5]李玲,王斌.藏红花对大鼠心肌缺血再灌注后心肌组织中缺氧诱导因子-1α、血管内皮生长因子表达的影响[J].中国老年学杂志,2013,33(22):5656-5657.
[6]屈玉春,王大伟,严夏,等.黄芪甲苷促进乳鼠心肌细胞自噬及抑制缺血诱导的心肌细胞凋亡作用研究[J]. 中药新药与临床药理,2014,25(02):169-172.
[7]王先宝.黄芩苷预处理通过抑制线粒体损伤介导的凋亡保护心肌缺血再灌注损伤[D].南方医科大学,2013.
[8]窦锦明,荆汉卫.黄芩总黄酮对大鼠心肌缺血再灌注损伤的保护作用[J].山东中医药大学学报,2013,37(01):50-52.
[9]徐京育,赵龙,张超越,等.芪桂益脉灵对急性心肌缺血再灌注损伤大鼠心肌组织P38MAPK信号通路的影响[J].中国中医药科技,2017,24(02):156-158,182.
[10]陈君,李蕾,陈国华,等.芪参益气滴丸对大鼠心肌缺血再灌注损伤的作用机制研究[J].中国现代医学杂志,2017,27(12):30-34.
[11]刘璇,李正,华声瑜,等.生脉注射液抗大鼠心肌缺血再灌注损伤的药理学研究[J].中成药,2015,37(02):251-255.
[12]乐智勇,秦晓林,方念伯,等.泽泻汤对心肌缺血再灌注损伤大鼠血流动力学的影响[J].湖北中医药大学学报,2012,14(05):3-5.
[13]韩宇博,田苗,郭维毅,等.苓桂术甘汤预防性给药对心肌缺血再灌注损伤NO、NOS含量的影响[J].中医药信息,2014,31(05):84-86.
[14]李卿,周春刚,张志斌.补阳还五汤防治心肌缺血/再灌注损伤的研究进展[J].医学综述,2015,21(11):2032-2034.
[15]苏泓洁,向小勇,赵兴吉,等.参附注射液对大鼠心肌缺血再灌注损伤保护作用的实验研究[J].重庆医科大学学报,2010,35(01):60-64.
[16]卞海,王雅娟,黄顺,等.瓜蒌薤白白酒汤对大鼠心肌缺血再灌注损伤的保护作用[J].中成药,2013,35(11):2347-2352.
[17]赵星宇,李洋,于小风,等.复方刺五加注射液对大鼠心肌缺血再灌注损伤的保护作用[J].中国老年学杂志,2008(06):535-537.
[18]王珺楠,刘斌,宋春莉.丹红注射液对大鼠心肌缺血损伤的保护作用[J].中国老年学杂志,2010,30(17):2481-2483.
[19]吴以岭.络病理论指导血管病变治疗研究[C]//中国中西医结合学会心血管病专业委员会.第一届全国中西医结合心血管病中青年医师论坛论文汇编.2008:5.
[20]刘芳.通心络胶囊治疗冠心病心绞痛的临床效果观察[J].中外医学研究,2017,15(17):12-14.
[21]陈静.通心络胶囊治疗冠心病PCI术后患者临床疗效及安全性的Meta分析[D].安徽中医药大学,2015.
[22]杨道阔.通心络胶囊治疗冠心病PCI术后心绞痛的临床观察[D].湖北中医药大学,2014.
[23]郭勇英,张军芳,贾存勤,等.通心络联合外周血间充质干细胞移植对糖尿病足大鼠血管新生HIF-1/VEGF通路及miR-210表达的影响[J].中国药理学通报,2015,31(12):1749-1754.
[24]张冰睿.通心络胶囊对心肌缺血大鼠血管新生功能的影响[J].泰山医学院学报,2015,36(06):636-639.
[25]王思颖.通心络对大鼠心肌梗死缺血区微血管新生及纤维化的作用机制研究[D].北京中医药大学,2016.
[26]沈菁,王超,张佳丽,等.电针内关穴对心肌缺血再灌注损伤家兔SOD与线粒体膜电位的影响[J].湖南中医药大学学报,2015,35(07):47-49,53.
[27]樊海龙,赵凌,任玉兰,等.针灸防治心肌缺血再灌注损伤的线粒体通路研究进展[J].世界中医药,2015,10(04):494-498.
[28]翟昌林,唐关敏,胡惠林,等.针灸预处理对大鼠心肌缺血再灌注后内质网应激的影响[J].中华危重症医学杂志(电子版),2014,7(03):172-176.
[29]阳晶晶,严洁,王超,等.针灸内关预处理对心肌缺血再灌注损伤兔血清NO、NOS及腺苷含量的影响[J]. 中国中医急症,2014,23(07):1209-1211,1227.
[30]王超,田岳凤,周丹,等.电针“内关”穴对心肌缺血再灌注大鼠心肌组织一氧化氮、一氧化氮合酶和细胞内钙的影响[J].针刺研究,2010,35(02):113-117.
[31]林海波,严洁,严小荣,等.针灸内关穴预处理对兔缺血再灌注损伤心肌细胞死亡受体通路Fas/FasL蛋白表达的影响[J].中华中医药杂志,2013,28(05):1286-1290.
[32]刘卫星,虞跃跃.温针灸预处理对不同时间间隔缺血再灌注大鼠心肌的保护作用[J].针灸临床杂志,2015,31(03):71-72.
[33]吴长岩,贾乐红,吕志军.温针灸对冠心病心绞痛发作频率及静息心电图的影响[J].针灸临床杂志,2009,25(06):32-34.
[34]柳培雨.miRNA-214/Ca2+信号通路在大鼠电针预处理心肌缺血-再灌注损伤保护中的作用[D].南方医科大学,2016.
[35]张佳丽.电针预处理对兔心肌缺血再灌注损伤腺苷A1受体、PKC的影响[D].湖南中医药大学,2014.
[36]老锦雄,潘清洁.背俞穴温针灸对冠心病无症状性心肌缺血患者心电图及血液动力学的影响[J].针灸临床杂志,2012,28(07):37-39.
[37]陈晨,孙忠人,吕晓琳,等.针灸预处理改善心肌缺血再灌注损伤机制的研究[J].针灸临床杂志,2016,32(11):102-106.

相似文献/References:

[1]车启富,何丽杰.中医辨证治疗老年不稳定型心绞痛的效果观察[J].医学信息,2018,31(02):141.[doi:10.3969/j.issn.1006-1959.2018.02.053]
[2]夏能能,任 薇,杜建平,等.1953~2016年中医药治疗高血压领域研究热点分析[J].医学信息,2018,31(04):18.[doi:10.3969/j.issn.1006-1959.2018.04.007]
　XIA Neng-neng,REN Wei,DU Jian-ping,et al.Analysis of Hot Spots in the Research of Traditional Chinese Medicine in Treating Hypertension from 1953 to 2016[J].Journal of Medical Information,2018,31(04):18.[doi:10.3969/j.issn.1006-1959.2018.04.007]
[3]杨少岩.中医药治疗中风后抑郁的研究[J].医学信息,2018,31(11):57.[doi:10.3969/j.issn.1006-1959.2018.11.018]
　YANG Shao-yan.Study on Treatment of Post-stroke Depression with Traditional Chinese Medicine[J].Journal of Medical Information,2018,31(04):57.[doi:10.3969/j.issn.1006-1959.2018.11.018]
[4]贺 佳,杜建强,聂 斌,等.智能问答系统在医学领域的应用研究[J].医学信息,2018,31(14):16.[doi:10.3969/j.issn.1006-1959.2018.14.007]
　HE Jia,DU Jian-qiang,NIE Bin,et al.Research on the Application of Intelligent Question-answering System in Medical Field[J].Journal of Medical Information,2018,31(04):16.[doi:10.3969/j.issn.1006-1959.2018.14.007]
[5]仇璐娜.慢性疲劳综合征的中医研究[J].医学信息,2018,31(21):48.[doi:10.3969/j.issn.1006-1959.2018.21.014]
　QIU Lu-na.TCM Research on Chronic Fatigue Syndrome[J].Journal of Medical Information,2018,31(04):48.[doi:10.3969/j.issn.1006-1959.2018.21.014]
[6]李 伟,陈素华.妊娠期人巨细胞病毒感染的中医药研究进展[J].医学信息,2019,32(01):37.[doi:10.3969/j.issn.1006-1959.2019.01.013]
　LI Wei,CHEN Su-hua.Advances in Research on Traditional Chinese Medicine for Human Cytomegalovirus Infection during Pregnancy[J].Journal of Medical Information,2019,32(04):37.[doi:10.3969/j.issn.1006-1959.2019.01.013]
[7]尚先宝.中医药防治老年骨质疏松骨折研究进展[J].医学信息,2019,32(11):45.[doi:10.3969/j.issn.1006-1959.2019.11.013]
　SHANG Xian-bao.Advances in Research on Prevention and Treatment of Senile Osteoporotic Fractures with Traditional Chinese Medicine[J].Journal of Medical Information,2019,32(04):45.[doi:10.3969/j.issn.1006-1959.2019.11.013]
[8]孙 鹏.腰椎椎管狭窄症的中医药治疗研究[J].医学信息,2019,32(17):57.[doi:10.3969/j.issn.1006-1959.2019.17.018]
　SUN Peng.Chinese Medicine Treatment of Lumbar Spinal Stenosis[J].Journal of Medical Information,2019,32(04):57.[doi:10.3969/j.issn.1006-1959.2019.17.018]
[9]徐忆芳,罗秀丽.基于数据挖掘的罗秀丽教授治疗三阴性乳腺癌的临床经验研究[J].医学信息,2019,32(20):159.[doi:10.3969/j.issn.1006-1959.2019.20.050]
　XU Yi-fang,LUO Xiu-li.Professor Luo Xiuli's Clinical Experience in Treating Triple-negative Breast Cancer Based on Data Mining[J].Journal of Medical Information,2019,32(04):159.[doi:10.3969/j.issn.1006-1959.2019.20.050]
[10]芶开来,李 明.中医药治疗股骨头坏死的临床研究现况[J].医学信息,2020,33(03):59.[doi:10.3969/j.issn.1006-1959.2020.03.018]
　GOU Kai Lai,LI Ming.Clinical Research on Treatment of Femoral Head Necrosis with Traditional Chinese Medicine[J].Journal of Medical Information,2020,33(04):59.[doi:10.3969/j.issn.1006-1959.2020.03.018]

更新日期/Last Update: 2018-02-15